A Study in Healthy Participants to Assess the Effect of Darunavir, Emtricitabine, and Tenofovir Alafenamide in the Presence of Cobicistat When Administered as a Fixed Dose Combination (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide) Compared to the Co-administration of the Separate Agents
Clinical trial NCT04236453 · TERMINATED
Trial details
- NCT number
- NCT04236453
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-23
- Primary completion
- 2020-04-10
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.